日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SETDB1 tumour suppressor roles in near-haploid mesothelioma involve TP53

SETDB1 肿瘤抑制因子在近单倍体间皮瘤中的作用涉及 TP53

Mengting Xu #, Yuqing Tu #, Wenhui Bi, Meijun Z Lundberg, Isabella Klooster, Jonathan A Fletcher, Wen-Bin Ou

Strategies to inhibit FGFR4 V550L-driven rhabdomyosarcoma

抑制 FGFR4 V550L 驱动的横纹肌肉瘤的策略

Elisa Fiorito #, Patrycja Szybowska #, Ellen M Haugsten, Michal Kostas, Geir F Øy, Antoni Wiedlocha, Sachin Singh, Sigve Nakken, Gunhild M Mælandsmo, Jonathan A Fletcher, Leonardo A Meza-Zepeda, Jørgen Wesche

E3 ligase MKRN3 is a tumor suppressor regulating PABPC1 ubiquitination in non-small cell lung cancer

E3连接酶MKRN3是一种肿瘤抑制因子,可调节非小细胞肺癌中PABPC1的泛素化。

Ke Li # ,Xufen Zheng # ,Hua Tang # ,Yuan-Sheng Zang # ,Chunling Zeng ,Xiaoxiao Liu ,Yanying Shen ,Yuzhi Pang ,Simin Wang ,Feifei Xie ,Xiaojing Lu ,Yuxiang Luo ,Zhang Li ,Wenbo Bi ,Xiaona Jia ,Tao Huang ,Rongqiang Wei ,Kenan Huang ,Zihao Chen ,Qingchen Zhu ,Yi He ,Miaoying Zhang ,Zhizhan Gu ,Yichuan Xiao ,Xiaoyang Zhang ,Jonathan A Fletcher ,Yuexiang Wang

YWHAE-NUTM2 oncoprotein regulates proliferation and cyclin D1 via RAF/MAPK and Hippo pathways

YWHAE-NUTM2 癌蛋白通过 RAF/MAPK 和 Hippo 通路调节增殖和细胞周期蛋白 D1

Wen-Bin Ou #, Meijun Z Lundberg #, Shuihao Zhu, Nacef Bahri, Anastasios Kyriazoglou, Liangliang Xu, Ting Chen, Adrian Mariño-Enriquez, Jonathan A Fletcher

Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours

胃肠道间质瘤中 CK2 和 KIT 的协同靶向治疗

Mengyuan Huang, Wenyu Yang, Jiaqing Zhu, Adrián Mariño-Enríquez, Chennianci Zhu, Jiaming Chen, Yuehong Wu, Yanping Quan, Haibo Qiu, Xuhui Li, Li Chai, Jonathan A Fletcher, Wen-Bin Ou

Preclinical Activity of PI3K Inhibitor Copanlisib in Gastrointestinal Stromal Tumor

PI3K 抑制剂 Copanlisib 在胃肠道间质瘤中的临床前活性

Alfonso García-Valverde, Jordi Rosell, Garazi Serna, Claudia Valverde, Joan Carles, Paolo Nuciforo, Jonathan A Fletcher, Joaquín Arribas #, Oliver Politz, César Serrano #

AXL Inactivation Inhibits Mesothelioma Growth and Migration via Regulation of p53 Expression

AXL 失活通过调节 p53 表达抑制间皮瘤生长和迁移

Wei Song, Hao Wang, Minmin Lu, Xinxin Ni, Nacef Bahri, Shuihao Zhu, Limin Chen, Yuehong Wu, Jieqiong Qiu, Jonathan A Fletcher, Wen-Bin Ou

LMTK3 is essential for oncogenic KIT expression in KIT-mutant GIST and melanoma

LMTK3 对 KIT 突变型 GIST 和黑色素瘤中的致癌 KIT 表达至关重要

Lillian R Klug, Amber E Bannon, Nathalie Javidi-Sharifi, Ajia Town, William H Fleming, Judy K VanSlyke, Linda S Musil, Jonathan A Fletcher, Jeffrey W Tyner, Michael C Heinrich

Genomic aberrations in cell cycle genes predict progression of KIT-mutant gastrointestinal stromal tumors (GISTs)

细胞周期基因的基因组畸变可预测 KIT 突变型胃肠道间质瘤 (GIST) 的进展

Michael C Heinrich #, Janice Patterson #, Carol Beadling, Yuexiang Wang, Maria Debiec-Rychter, Barbara Dewaele, Christopher L Corless, Anette Duensing, Chandrajit P Raut, Brian Rubin, Tamas Ordog, Matt van de Rijn, Jerry Call, Thomas Mühlenberg, Jonathan A Fletcher #, Sebastian Bauer #1

Gastrointestinal stromal tumor enhancers support a transcription factor network predictive of clinical outcome

胃肠道间质瘤增强子支持预测临床结果的转录因子网络

Matthew L Hemming, Matthew A Lawlor, Rhamy Zeid, Tom Lesluyes, Jonathan A Fletcher, Chandrajit P Raut, Ewa T Sicinska, Frédéric Chibon, Scott A Armstrong, George D Demetri, James E Bradner